π« Check out the new article in the inaugural issue of the new EANM Journal:
EANM insights on PET-based response assessment in neuro-oncology: things are moving forward!
doi.org/10.1016/j.ea...
@eanm.org
@nmnsymposium.bsky.social
Advancing Nuclear Medicine and Neurooncology through research and education. Join the #NMN2025 Symposium on May 09/10th 2025 in Vienna, Austria. nmn-society.org
π« Check out the new article in the inaugural issue of the new EANM Journal:
EANM insights on PET-based response assessment in neuro-oncology: things are moving forward!
doi.org/10.1016/j.ea...
@eanm.org
Weβre thrilled to see so many high-quality submissions coming in for our journals! π
Explore the latest publications and the editorials written by our EANM Board and Editors-in-Chief:
π The EANM Journal: sciencedirect.com/journal/the-...
π EANM Innovation: sciencedirect.com/journal/eanm...
π¨New paper in EJNMMI: [177Lu]Lu-DOTATATE for refractory meningiomas: factors associated with the therapeutic response and initial tumor dosimetric data.
link.springer.com/article/10.1...
Whoβs ready for 2025 WFNOS/SNO Annual meeting in Honolulu?!
Register by Sept 19 to get early bird pricing and join colleagues from around the world in advancing #neurooncology.
soc-neuro-onc.org/SNO2025
π§ EANS-EANO Guidelines on the extent of resection in gliomas.
academic.oup.com/neuro-oncolo...
@eanoassociation.bsky.social @neuroonc.bsky.social
π¨ π« Happy to share that that @eortc.org is a π collaboration partner for the #NMN2026 Symposium: www.nmn-society.org!
@nathaliealbert.bsky.social
π¨ New publication in Journal of Nuclear Medicine: Retrospective Evaluation of the Correlation Between Somatostatin Receptor PET/CT and Histopathology in Patients with Suspected Intracranial Meningiomas.
jnm.snmjournals.org/content/earl...
π β’οΈ π©Ί Implementation of Radiotheranostics: Challenges, Barriers, and IAEA-Driven Strategies for Sustainable Access.
www.sciencedirect.com/science/arti...
New publication in Nature Reviews Clinical Oncology: The molecular blueprint of targeted radionuclide therapy.
www.nature.com/articles/s41...
Prognostic value of [18F]FET-PET in diffuse low-grade (grade 2) gliomas after the 2021 classification of CNS tumors.
link.springer.com/article/10.1...
Assessment of 18F-FET PET-based response in patients with gliomas using the PET RANO 1.0 criteria.
academic.oup.com/noa/advance-...
π¨ Registration deadline for the EACR conference on #cancerneuroscience is September 15 βΌοΈ
Please join us in beautiful Bilbao for exciting discussions on the dialogue between the nervous system and cancer π¬π§
See you soon!
Tumor Versus Capillary Telangiectasia in Recurring Glioblastoma.
journals.lww.com/nuclearmed/f...
@nathaliealbert.bsky.social
Thank you! We're pleased to support the #NMN2026 Symposium and collaborate with colleagues across the global neuro-oncology community. ππ§ #EANO #Collaboration #NeuroOncology
05.09.2025 17:46 β π 1 π 1 π¬ 0 π 0Prediction of progression-free and overall survival following temozolomide chemoradiation using FET PET-based parameters including radiomics in patients with glioblastoma.
ο»Ώacademic.oup.com/noa/advance-...
π€© Happy to share that the EANO is endorsing the #NMN2026 Symposium: www.nmn-society.org! π« Excited to join forces with the leading mulitdisciplinary neuro-oncology society in Europe π !
www.eano.eu
@eanoassociation.bsky.social @nathaliealbert.bsky.social @michael-platten.bsky.social
Spatial tumour characteristics as an indirect marker of metabolic dysregulation: evaluation for non-invasive IDH-genotyping of glioma using hybrid [18 F]FET-PET/MRI.
ο»Ώlink.springer.com/article/10.1...
βοΈNew Article published at Nature Cancer!
'Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling'
βοΈBy Wies Vallentgoed and colleagues
π www.nature.com/articles/s43...
Convection-enhanced delivery of [225Ac]Ac-DOTA-SP in recurrent glioblastoma β tumour uptake.
link.springer.com/article/10.1...
π₯ Hot off the press in Neuro-Oncology by @mj-mair.bsky.social et al: Prognostic stratification of newly diagnosed IDH-mutant gliomas by [18F]fluoroethyltyrosine and [11C]methionine PET β a retrospective, bicentric cohort study.
academic.oup.com/neuro-oncolo...
@eanoassociation.bsky.social
Early seizure freedom with [18F]fluorodopa positron emission tomography response after isocitrate dehydrogenase inhibition with vorasidenib: First case report.
onlinelibrary.wiley.com/doi/full/10....
The role of amino acid PET in the era of checkpoint inhibitors and targeted therapy for brain tumor treatment.
journals.lww.com/co-neurology...
π§ Just published in Neuro-Oncology: A comprehensive consensus review by @neuroonc.bsky.social and EANO on current management and future directions in adult #Glioblastoma care. Explore key recommendations and research priorities.
π academic.oup.com/neuro-oncolo...
#NeuroOncology
The use of minor response, volumetric assessment, and growth rate kinetics as endpoints in grade 1-3 glioma clinical trials: a RANO perspective.
academic.oup.com/neuro-oncolo...
@eanoassociation.bsky.social @neuroonc.bsky.social
Have you read the new edition of our #ICOM newsletter?
In it, you can read about the latest #meningioma-related events and articles from our members.
adobe.ly/45yJe1R
π₯ Hot of the press in Neuro-Oncology! π§ #Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions.
academic.oup.com/neuro-oncolo...
@eanoassociation.bsky.social @neuroonc.bsky.social
π€© Happy to share that the Asian Society for Neuro-Oncology (ASNO) is endorsing the #NMN2026 Symposium: www.nmn-society.org! π Looking forward to this collaboration to advance Nuclear Medicine and Neuro-Oncology on a global level!
www.a-sno.org
@nathaliealbert.bsky.social
π₯ Hot off the press in JNM: [177Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II Trial. π©Ί Study enrollment is ongoing.
jnm.snmjournals.org/content/earl...
@nathaliealbert.bsky.social @journalofnucmed.bsky.social @eortc.org
EANO and @neuroonc.bsky.social welcome @wickwolfgang.bsky.social, MD as the new Editor-in-Chief of Neuro-Oncology Advances! Thanks to @gelarehzadeh.bsky.social for seven years of outstanding leadership. Exciting new chapter ahead!
#NeuroOncology #EANO #SNO #NeuroOncologyAdvances